Developer of an open XDR platform designed to characterize every aspect of modern attacks while remaining intuitive to understand. The company's platform delivers threat detection and response technology by ingesting data from all tools, automatically detecting and correlating alerts into incidents across the entire attack surface, enabling enterprises to reduce risk through early and precise identification and remediation of all attack activities while slashing costs, retaining investments in existing tools and accelerating analyst productivity.
San Jose, United States of AmericaSoftware & SaaSMidsize
The University of Zurich (UZH) is a public research university in Zurich, Switzerland, and the largest university in the country, offering a broad range of degree programs and conducting leading research across disciplines.
Blue J is a tax technology company based in New York, founded in 2015. It specializes in generative AI solutions for tax research and advisory services, catering to tax professionals in various accounting firms. The company aims to simplify complex tax law by transforming it into structured data, providing quick and reliable answers to intricate tax questions through a conversational AI interface.
The core offering of Blue J is its generative AI platform, which enhances workflows from research to client deliverables. Key features include instant answers with verifiable citations, a curated content library for in-depth analysis, and drafting tools for creating client-ready documents. The platform also offers advanced capabilities such as predictive analytics, scenario testing, and custom reporting. Blue J is trusted by numerous accounting firms, including RSM, and emphasizes security and support with SOC 2 compliance and tailored enterprise solutions.
Mizuho OSI is a world-leading manufacturer of highly specialized surgical tables, pressure management solutions, and consumables for spine, orthopedic trauma, total hip replacements, hip arthroscopy, and related procedures, focused on improving surgical outcomes and patient safety.